Meeting

COT Meeting: 1st December 2020

Agenda and papers for the meeting of the Committee at 10.00am on Tuesday 1st December 2020 via Microsoft Teams

Last updated: 27 November 2020

Meeting Agenda

1. Apologies for absence


2. Draft minutes of October meeting TOX/MIN/2020/07

 

3. Matters arising -  Discussion on new ways of working.

 

4. Review of the dioxin tolerable daily intake (TDI) : Draft
problem formulation statement TOX/2020/57

 

5. Third draft overarching statement on potential risks from exposure to microplastics TOX/2020/58

 

6. A summary of data published to date on the presence and pharmacokinetics of nicotine salts in electronic nicotine delivery systems (ENDS) products. TOX/2020/59

 

7. First Draft Statement on the EFSA Opinion “on the risks to human health related to the presence of perfluoroalkyl substances in food” TOX/2020/60

 

8. First draft statement on the potential effects of excess iodine intake may have during preconception, pregnancy and lactation  TOX/2020/61

 

9. Potential adverse effects associated with exposure to cannabidiol (CBD) by inhalation. TOX/2020/62

 

10. EU Exit (Reserved)
• Update on Regulated products TOX/2020/63
• Regulated product dossier assessment template TOX/2020/64
• Problem formulation statement TOX/2020/65
• Presentation on regulated product assessment by the EFSA panels

 

11. Update on the work of other advisory committees TOX/2020/66

 

12. Any other business

 

Next meeting of the Committee at 10.00am on Tuesday 2nd February 2021 via Skype and TEAMs

Media discussed during the meeting

Please see information on reserved items on the Procedure for holding COT meetings in open session page

TOX MIN 2020 - 07

Draft minutes of the meeting of the Committee at 10:00am on 27th October via Microsoft Teams

TOX 2020 - 57

Review of the dioxin tolerable daily intake (TDI): Draft problem formulation statement

TOX 2020 - 58

Third draft overarching statement on potential risks from Exposure to microplastics

Annex A of TOX 2020 - 58

Annex A of third draft overarching statement on potential risks from exposure to microplastics

TOX 2020 - 59

A summary of data published to date on the presence and pharmacokinetics of nicotine salts in electronic nicotine delivery systems (ENDS) products

TOX 2020 - 60

First draft statement on the EFSA Opinion "on the risks to human health related to the presence of perfluoroalkyl substances in food"

TOX 2020 - 61

First draft statement on the potential effects of excess iodine intake may have during preconception, pregnancy and lactation

TOX 2020 - 62

Potential adverse effects associated with exposure to cannabidiol (CBD) by inhalation 

TOX 2020 - 63

EU Exit (reserved) 

Update on Regulated products

TOX 2020 - 64

EU Exit (reserved) 

Regulated product dossier assessment template

TOX 2020 - 65

EU Exit (reserved) 

Problem formulation statement 

Presentation on regulated product assessment by the EFSA panels

TOX 2020 - 66

An update on the work of other advisory committees

COT Meeting : 1st December 2020 Agenda

Meeting of the Committee at 10:00, 1st December 2020 via Microsoft Teams

 

Final minutes of the meeting of the Committee on 1st December 2020

*PDF coming soon*

The final minutes of the meeting of the Committee held on Tuesday 1st December 2020 via Microsoft Teams